Delivery Order SPE2DB24D2100-SPE2DB25FBGEN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,052.93 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5mL) on June 2, 2025, with completion scheduled for June 3, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $30,940.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringe units (0.5ML) on September 12, 2025, with an ultimate completion date of September 15, 2025. This non-set-aside contract represents a competitive award for pharmaceutical supply delivery to support federal medical procurement needs. The order will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- On August 25, 2025, the Defense Logistics Agency awarded a delivery order valued at $126,623.96 to AmerisourceBergen Drug Corp for the supply of Prevnar 20 syringes (0.5 mL). This firm fixed-price delivery order, with an ultimate completion date of August 26, 2025, represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $5,126.96 delivery order to AmerisourceBergen Drug Corp on June 26, 2025, for the supply of PREVNAR 20 syringes in 0.5ML units. This contract is classified as a child delivery order under a firm fixed-price arrangement with no set-aside designation, and is scheduled for ultimate completion on June 27, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a $36,998.71 firm fixed price delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5mL syringes. This non-competitive delivery order, issued on September 12, 2025, with an ultimate completion date of September 15, 2025, represents a routine pharmaceutical procurement fulfilling ongoing federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor within the...
- The Defense Logistics Agency awarded a delivery order valued at $47,295.80 to AmerisourceBergen Drug Corp for the supply of PREVNAR 20 syringes (0.5mL) with a completion date of September 10, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location in the same city....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of PREVNAR 20 syringe vaccines (0.5mL) valued at $30,403.64. This firm fixed-price delivery order represents a non-set-aside competitive award with an ultimate completion date of August 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (SPE2DX) with...
- The Defense Logistics Agency awarded a $16,337.70 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Prevnar 20 syringes (0.5 mL). This competitively awarded, firm fixed-price delivery order represents a continuation of pharmaceutical supply services under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract specifies performance at the vendor's Conshohocken, Pennsylvania location, with an ultimate completion date...
- The Defense Logistics Agency awarded a $40,118.88 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 syringe supply (0.5mL) under a firm fixed-price contract. The delivery order, issued on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Prevnar 20 syringes (0.5mL) with a ceiling value of $9,802.68. This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The contract is set to be completed by July 31, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBGENDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $35,155.89 to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of PREVNAR 20 syringe units (0.5ML). This contract represents a firm fixed price delivery order with no set-aside designation, indicating competitive award through open market solicitation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is scheduled for ultimate completion by September 8, 2025. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems globally. The PREVNAR 20 vaccine delivery supports the Defense Health Agency and other government healthcare systems' immunization programs, with the company demonstrating significant capability in fulfilling federal medical supply requirements across multiple therapeutic domains through its established relationship with DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $35.2k | 9/5/25 |